Uswm Ct, Llc
Clinical trials sponsored by Uswm Ct, Llc, explained in plain language.
-
Supercharged immune cells target Hard-to-Treat cancers
Disease control OngoingThis study tests whether genetically modified immune cells can safely shrink tumors in people with advanced synovial sarcoma or liposarcoma. Researchers collect patients' own T-cells, engineer them to recognize cancer proteins, then infuse them back into the body. The trial is fo…
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental immune cell treatment tested against nine deadly cancers
Disease control OngoingThis early-stage trial is testing the safety of a new treatment called ADP-A2M4CD8, which uses a patient's own modified immune cells to fight cancer. The study will enroll 120 adults with one of nine advanced cancers who have specific genetic markers. Researchers will give the ce…
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Experimental immune therapy targets Tough-to-Treat sarcomas
Disease control OngoingThis study is testing whether a personalized immune cell therapy can help control advanced synovial sarcoma or myxoid liposarcoma. Doctors take a patient's own immune cells, genetically modify them to recognize cancer, and infuse them back. The trial will measure how well tumors …
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Experimental immune cell therapy targets Tough-to-Treat sarcomas
Disease control OngoingThis study tests an experimental treatment called Lete-Cel, which uses a patient's own genetically modified immune cells to fight two types of advanced soft tissue cancer: synovial sarcoma and myxoid/round cell liposarcoma. It involves 87 participants whose cancers have progresse…
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Scientists test re-engineered immune cells to fight tough ovarian cancer
Disease control OngoingThis study is testing a new personalized treatment for ovarian cancer that has come back. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The trial is seeing if these modified cells work better alone or when …
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC